SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-154233
Filing Date
2023-05-25
Accepted
2023-05-25 16:20:53
Documents
14
Period of Report
2023-05-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d473409d8k.htm   iXBRL 8-K 38020
2 EX-3.1 d473409dex31.htm EX-3.1 7016
3 EX-3.2 d473409dex32.htm EX-3.2 5559
  Complete submission text file 0001193125-23-154233.txt   185939

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20230523.xsd EX-101.SCH 2839
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20230523_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20230523_pre.xml EX-101.PRE 12146
8 EXTRACTED XBRL INSTANCE DOCUMENT d473409d8k_htm.xml XML 3664
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 23960922
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences